| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 115103-54-3 | 噻加賓; (3R)-1-[4,4-雙(3-甲基噻吩-2-基)丁-3-烯基]哌啶-3-甲酸 | TiAGABine; (3R)-1-[4,4-Bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid |  | C20H25NO2S2 | 詳情 | 供應(yīng)商 |
| 145821-59-6 | 鹽酸噻加賓; (3R)-1-[4,4-雙(3-甲基噻吩-2-基)丁-3-烯基]哌啶-3-甲酸鹽酸鹽 | TiAGABine hydrochloride; (3R)-1-[4,4-Bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid hydrochloride |  | C20H26ClNO2S2 | 詳情 | 供應(yīng)商 |
| 107030-45-5 | Benzo[d]-1,3-dioxolo[4,5-g]pyrido[4,3,2-jk][2]benzazepine,5,6,7,7a-tetrahydro-7-methyl- (9CI); DrAGABine |  | C18H16N2O2 | 詳情 | 供應(yīng)商 | |
| 115103-55-4 | 3-Piperidinecarboxylicacid, 1-[4,4-bis(3-methyl-2-thienyl)-3-buten-1-yl]-, (3S)-; 3-Piperidinecarboxylicacid, 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-, (3S)- (9CI); 3-Piperidinecarboxylic acid, 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-, (S)-; (S)-TiAGABine; NO 05-0329; NO 329 |  | C20H25NO2S2 | 詳情 | 供應(yīng)商 | |
| 145821-58-5 | 3-Piperidinecarboxylicacid, 1-[4,4-bis(3-methyl-2-thienyl)-3-buten-1-yl]-, ethyl ester, (3R)-; 3-Piperidinecarboxylicacid, 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-, ethyl ester, (3R)- (9CI); 3-Piperidinecarboxylic acid, 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-, ethylester, (R)-; Ethyl(3R)-1-[4,4-bis(3-methylthien-2-yl)-3-butenyl]piperidine-3-carboxylate; EthyltiAGABinate |  | C22H29NO2S2 | 詳情 | 供應(yīng)商 | |
| 128201-89-8 | 4-[[(5Z,8Z,11Z,14Z)-1-OXO-5,8,11,14-EICOSATETRAENYL]AMINO]BUTANOIC ACID; NAGABA; N-ARACHIDONOYL-GAMMA-AMINOBUTYRIC ACID; N-ARACHIDONYLGABA; 4-[[(5Z,8Z,11Z,14Z)-1-OXO-5,8,11,14-EICOSATETRAENYL]AMINO]BUTANOIC ACID; 4-[(1-OXO-5Z,8Z,11Z,14Z-EICOSATETRAENYL)AMINO]-BUTANOIC ACID; N-ArachidonoylGABA |  | C24H39NO3 | 詳情 | 供應(yīng)商 |